ARTICLE | Company News
Chiron grants HCV license
April 17, 2000 7:00 AM UTC
CHIR granted Glaxo Wellcome (LSE:GLXO; GLX) a non-exclusive license to its hepatitis C virus (HCV) patent portfolio to develop and commercialize small molecule therapeutics against HCV. ...